Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
Open Access
- 6 September 2022
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 10 (1) , 1-13
Abstract
The pathological hallmarks of Parkinson’s disease (PD) are α-synuclein (αSYN)-positive inclusions referred to as Lewy bodies and Lewy neurites, collectively referred to as Lewy-related pathology (LRP). LRP is thought to propagate in an ascending manner throughout the brain as the disease progresses. LRP is visible with histologic methods and is thought to represent a later stage of the disease process, while αSYN oligomers, which are not visible with routine histologic methods, are considered earlier. There is increasing evidence to suggest that αSYN oligomers may be more toxic than visible LRP. Detecting αSYN oligomers requires special techniques, and their distribution and association with clinical features are important research objectives. In this report, we describe the distribution of αSYN oligomers in multiple cortical and subcortical regions of PD using a proximity ligation assay (PLA). We observe widespread distribution of αSYN oligomers with PLA and more restricted distribution of LRP with αSYN immunohistochemistry. The distribution of αSYN oligomers differed from LRP in that αSYN oligomer burden was significantly greater in the neocortex, while LRP was greater in vulnerable subcortical regions, including the brainstem. We also found that cognitive impairment was associated with αSYN oligomers in the hippocampus. These results suggest that αSYN oligomers may be widely distributed in PD early in the disease process and that they may contribute to cognitive impairment in PD.Keywords
Funding Information
- Uehara Memorial Foundation
- Japanese Society of Neurology
- The Cell Science Research Foundation
- Ministry of Health, Labour and Welfare
This publication has 48 references indexed in Scilit:
- Direct Observation of the Interconversion of Normal and Toxic Forms of α-SynucleinCell, 2012
- In vivo demonstration that α-synuclein oligomers are toxicProceedings of the National Academy of Sciences, 2011
- Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunctionActa Neuropathologica, 2009
- Invited Article: Nervous system pathology in sporadic Parkinson diseaseNeurology, 2008
- Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 yearsNature Medicine, 2008
- Applicability of current staging/categorization of α-synuclein pathology and their clinical relevanceActa Neuropathologica, 2008
- The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α‐synuclein stagingNeuropathology and Applied Neurobiology, 2007
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991